4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,070.00p
   
  • Change Today:
      25.00p
  • 52 Week High: 1,100.00
  • 52 Week Low: 500.00
  • Currency: UK Pounds
  • Shares Issued: 12.81m
  • Volume: 3,229
  • Market Cap: £137.02m

Regulatory News

4basebio Plc - 4basebio announces the supply of ... 10-Apr-2024 07:00 PR Newswire
4basebio Plc - 4basebio client's Phase I clinica... 21-Mar-2024 07:00 PR Newswire
4basebio Plc - 4basebio awarded tender to delive... 01-Mar-2024 07:00 PR Newswire
4basebio Plc - Holding(s) in Company 06-Feb-2024 07:01 PR Newswire
4basebio Plc - Holding(s) in Company 06-Feb-2024 07:01 PR Newswire
4basebio Plc - Holding(s) in Company 06-Feb-2024 07:01 PR Newswire
4basebio Plc - Holding(s) in Company 06-Feb-2024 07:01 PR Newswire
4basebio Plc - Exercise of Options 06-Feb-2024 07:00 PR Newswire
4basebio Plc - Holding(s) in Company 05-Feb-2024 07:01 PR Newswire
4basebio Plc - Holding(s) in Company 05-Feb-2024 07:01 PR Newswire
4basebio Plc - Holding(s) in Company 05-Feb-2024 07:01 PR Newswire
4basebio Plc - Directors' Dealings 05-Feb-2024 07:00 PR Newswire
4basebio Plc - Long-Term Incentive Plan and Exer... 02-Feb-2024 07:00 PR Newswire
4basebio Plc - Half-year Report 21-Sep-2023 07:00 PR Newswire
4basebio Plc - Grant received from the Bill and ... 01-Aug-2023 07:00 PR Newswire
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,070.00p
Change Today 25.00p
% Change 2.39 %
52 Week High 1,100.00
52 Week Low 500.00
Volume 3,229
Shares Issued 12.81m
Market Cap £137.02m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.62% below the market average69.62% below the market average69.62% below the market average69.62% below the market average69.62% below the market average
28.3% below the sector average28.3% below the sector average28.3% below the sector average28.3% below the sector average28.3% below the sector average
Price Trend
97.02% above the market average97.02% above the market average97.02% above the market average97.02% above the market average97.02% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
35.13% below the market average35.13% below the market average35.13% below the market average35.13% below the market average35.13% below the market average
51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average

4basebio Dividends

No dividends found

Trades for 24-Apr-2024

Time Volume / Share Price
14:58 925 @ 1,084.00p
15:07 25 @ 1,100.00p
14:41 91 @ 1,084.00p
11:25 320 @ 1,085.00p
10:49 1,868 @ 1,070.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page